A study to find out whether a new medicine (DHES0815A) was safe and effective in patients with breast cancer

Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer

Cancer
Breast Cancer

Results
Download
Print

Study results

LPS_GO39869_final results_November2021_English (PDF, 0.1 MB)

LPS_GO39869_final results_November2021_Korean (PDF, 0.2 MB)

LPS_GO39869_final results_November2021_Spanish-US (PDF, 0.1 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study to find out whether a new medicine (DHES0815A) was safe and effective in patients with breast cancer

Study results

LPS_GO39869_final results_November2021_English (PDF, 0.1 MB)

LPS_GO39869_final results_November2021_Korean (PDF, 0.2 MB)

LPS_GO39869_final results_November2021_Spanish-US (PDF, 0.1 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A study to find out whether a new medicine (DHES0815A) was safe and effective in patients with breast cancer

For the latest version of this information please go to www.forpatients.roche.com